The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein.
Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet.
The English language version is always the official and authoritative version of this website.
NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window.
Synopsis As Introduced Amends the Pharmacy Practice Act. Provides that beginning January 1, 2016, the Department of Financial and Professional Regulation shall implement a pilot project requiring that every new or refilled prescription for a Schedule II controlled substance containing hydrocodone shall only be dispensed in a non-reusable medicine locking closure package. Defines "medicine locking closure package" and "Schedule II controlled substance". Provides that the medicine locking closure package must be dispensed by the pharmacy with instructions for patient use. Provides that the manufacturer of the medicine locking closure package must make available assistance online or through a toll-free number for patient use. Provides that prescriptions reimbursed via Medicare Part D and Medicaid and prescriptions for individuals residing in facilities licensed under the Nursing Home Care Act are exempt from the requirements of the pilot project. Repeals the provisions creating the pilot project on January 1, 2017. Effective immediately.
Replaces everything after the enacting clause. Amends the Pharmacy Practice Act. Creates a pilot project requiring that Schedule II controlled substances containing hydrocodone be dispensed in non-reusable medicine locking closure packages with instructions for patient use, and provides that the pilot program only applies to pharmacies that voluntarily choose to participate. Provides that the Department of Financial and Professional Regulation shall not expend more than $150,000 on the pilot program. Exempts prescriptions reimbursed via the Medicare Part D and Medicaid programs from the pilot program and prescriptions for individuals residing in facilities licensed under the Nursing Home Care Act. Repeals the pilot program provisions on January 1, 2017. Makes changes to requirements to become a registered certified pharmacy technician. Changes various references from "certified pharmacy technician" to "registered certified pharmacy technician". In the requirements an applicant for registration as a registered certified pharmacy technician must meet, requires passage of an examination accredited by the National Commission for Certifying Agencies (rather than the National Organization of Certifying Agencies). Makes changes to requirements for renewal of a certificate of registration as a registered certified pharmacy technician under the Act, and creates continuing education requirements. Removes certain requirements to become a pharmacy investigator. Provides that pharmacy investigators must be licensed pharmacists unless employed as a pharmacy investigator on or before the effective date of the amendatory Act. Effective immediately, except for provisions concerning registered certified pharmacy technicians, which take effect January 1, 2017.
Senate Floor Amendment No. 1 Provides that a prescriber may indicate orally, in writing, or electronically that a locking closure package shall not be used. Provides that the Department of Financial and Professional Regulation may contract with third parties to implement the pilot program. Makes other changes. Changes the effective date of certain provisions from January 1, 2017 to immediate.
This site is maintained for the Illinois General Assembly
by the Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706
Contact ILGA Webmaster